Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

20.40 

0.00 0.0%

as of Dec 11 '19

52 Week Range:

17.36 21.56


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Kirin Holdings Company, Limited manufactures and sells alcoholic and non-alcoholic beverages, and pharmaceuticals and bio-chemicals in Japan and internationally. It operates through four segments: Japan Integrated Beverages Business, Oceania Integrated Beverages Business, Other Overseas Integrated Beverages Business, and Pharmaceuticals and Bio-Chemicals Business. The company's products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the livestock feed and theme park businesses; and management and operation of a chain of Kirin City beer pubs; manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, as well as sake; and manufacture and supply of Four Roses bourbon. Kirin Holdings Company, Limited has a strategic collaboration with Mitsui & Co., Ltd. and Onegevity Health for launching a testing system in Japan, as well as to develop nutritional products. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 8.18
7.67
8.94
9.91
7.91
7.82
8.07
6.55
5.32
7.26
8.24
growth rate -6.2% 16.6% 10.9% -20.2% -1.1% 3.2% -18.8% -18.8% 36.5% 13.5%
Earnings BIT 142,818.00
114,550.00
108,732.00
179,529.00
185,809.00
183,011.00
growth rate -19.8% -5.1% 65.1% 3.5% -1.5%
Avg.PE 13.87
14.99
8.64
7.84
growth rate 8.1% -42.4% -9.3%
ROA 3.15
1.79
0.41
0.27
1.94
2.93
1.11
-1.75
4.93
10.20
6.98
growth rate -43.2% -77.1% -34.2% 618.5% 51.0% -62.1% -100.0% 100.0% 106.9% -31.6%
ROE 8.39
5.00
1.17
0.82
6.24
8.46
2.97
-5.36
17.56
29.54
17.52
growth rate -40.4% -76.6% -29.9% 661.0% 35.6% -64.9% -100.0% 100.0% 68.2% -40.7%
ROIC 6.05
3.47
1.43
1.06
3.67
5.20
2.53
-2.15
9.11
17.76
11.82
growth rate -42.6% -58.8% -25.9% 246.2% 41.7% -51.4% -100.0% 100.0% 95.0% -33.5%
Cur. Ratio 1.15
1.06
1.07
1.06
1.10
1.23
1.02
1.17
1.15
1.41
1.41
growth rate -7.8% 0.9% -0.9% 3.8% 11.8% -17.1% 14.7% -1.7% 22.6% 0.0%
Quick Ratio 0.72
0.69
0.69
0.67
0.69
0.77
0.58
0.69
0.70
0.91
0.99
growth rate -4.2% 0.0% -2.9% 3.0% 11.6% -24.7% 19.0% 1.5% 30.0% 8.8%
Leverage 2.66
2.92
2.75
3.35
3.11
2.69
2.69
3.68
3.45
2.50
2.51
growth rate 9.8% -5.8% 21.8% -7.2% -13.5% 0.0% 36.8% -6.3% -27.5% 0.4%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 409,000.00
392,253.00
405,089.00
393,213.00
434,229.00
402,296.00
404,934.00
growth rate -4.1% 3.3% -2.9% 10.4% -7.4% 0.7%
Acct.Payable 151,184.00
155,863.00
160,106.00
142,052.00
189,342.00
167,551.00
166,325.00
growth rate 3.1% 2.7% -11.3% 33.3% -11.5% -0.7%
Cur.Assets 789,496.00
814,788.00
801,830.00
781,933.00
768,511.00
872,221.00
831,758.00
growth rate 3.2% -1.6% -2.5% -1.7% 13.5% -4.6%
Total Assets 2,951,061.00
2,896,456.00
2,965,868.00
2,443,773.00
2,422,825.00
2,398,572.00
2,303,624.00
growth rate -1.9% 2.4% -17.6% -0.9% -1.0% -4.0%
Cash 78,042.00
113,759.00
40,545.00
60,337.00
66,499.00
160,913.00
173,102.00
growth rate 45.8% -64.4% 48.8% 10.2% 142.0% 7.6%
Inventory 206,501.00
225,045.00
246,264.00
227,726.00
205,190.00
195,136.00
204,837.00
growth rate 9.0% 9.4% -7.5% -9.9% -4.9% 5.0%
Cur.Liabilities 718,137.00
659,898.00
784,671.00
665,913.00
685,464.00
612,960.00
589,949.00
growth rate -8.1% 18.9% -15.1% 2.9% -10.6% -3.8%
Liabilities 1,797,160.00
1,595,731.00
1,630,157.00
1,505,690.00
1,463,637.00
1,169,433.00
1,102,704.00
growth rate -11.2% 2.2% -7.6% -2.8% -20.1% -5.7%
LT Debt 768,584.00
642,667.00
569,000.00
598,943.00
511,536.00
362,622.00
317,937.00
growth rate -16.4% -11.5% 5.3% -14.6% -29.1% -12.3%
Equity 1,076,167.00
1,102,167.00
664,273.00
706,124.00
957,828.00
916,080.00
growth rate 2.4% -39.7% 6.3% 35.7% -4.4%
Common Shares 954.00
954.00
955.00
1,037.00
981.00
944.00
919.00
913.00
913.00
913.00
895.00
growth rate 0.0% 0.1% 8.6% -5.4% -3.8% -2.7% -0.7% 0.0% 0.0% -2.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 98,977.00
117,393.00
120,480.00
77,116.00
99,397.00
88,828.00
87,885.00
growth rate 18.6% 2.6% -36.0% 28.9% -10.6% -1.1%
Cash Dividends 31,921.00
34,081.00
34,676.00
34,676.00
36,959.00
44,823.00
growth rate 6.8% 1.8% 0.0% 6.6% 21.3%
Cash From OA 212,061.00
205,517.00
155,247.00
171,011.00
232,263.00
221,710.00
198,051.00
growth rate -3.1% -24.5% 10.2% 35.8% -4.5% -10.7%
FCF per Share 0.22
0.24
1.04
1.33
0.81
0.64
0.41
0.61
0.89
1.32
0.90
growth rate 9.1% 333.3% 27.9% -39.1% -21.0% -35.9% 48.8% 45.9% 48.3% -31.8%
Sale Purchase of Stock 25.00
growth rate
FCF 5,218.00
79,661.00
111,375.00
116,962.00
113,084.00
88,124.00
34,767.00
93,895.00
131,437.00
132,882.00
110,166.00
growth rate 1,426.7% 39.8% 5.0% -3.3% -22.1% -60.6% 170.1% 40.0% 1.1% -17.1%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 1,870,627.00
2,254,585.00
1,894,429.00
1,891,227.00
1,853,937.00
1,863,730.00
1,930,522.00
growth rate 20.5% -16.0% -0.2% -2.0% 0.5% 3.6%
Op.Income 73,463.00
142,818.00
114,550.00
108,732.00
179,529.00
185,809.00
183,011.00
growth rate 94.4% -19.8% -5.1% 65.1% 3.5% -1.5%
IBT 157,205.00
77,878.00
17,421.00
208,151.00
233,710.00
246,852.00
growth rate -50.5% -77.6% 1,094.8% 12.3% 5.6%
Net Income 73,463.00
85,656.00
32,392.00
-47,329.00
148,918.00
241,991.00
164,202.00
growth rate 16.6% -62.2% -100.0% 100.0% 62.5% -32.2%
EPS 84.01
51.54
11.93
7.14
57.31
90.73
35.24
-51.87
163.18
265.14
183.53
growth rate -38.7% -76.9% -40.2% 702.7% 58.3% -61.2% -100.0% 100.0% 62.5% -30.8%
Gross Profit 911,704.00
966,995.00
943,480.00
968,071.00
787,295.00
812,563.00
833,369.00
growth rate 6.1% -2.4% 2.6% -18.7% 3.2% 2.6%
R&D 54,049.00
57,039.00
61,250.00
62,874.00
growth rate 5.5% 7.4% 2.7%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 60,045.00
35,771.00
-29,794.00
42,728.00
48,125.00
growth rate -40.4% -100.0% 100.0% 12.6%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 368,154.00
404,934.00
360,018.00
378,154.00
332,905.00
growth rate 10.0% -11.1% 5.0% -12.0%
Acct.Payable 204,732.00
166,325.00
213,979.00
213,154.00
203,874.00
growth rate -18.8% 28.7% -0.4% -4.4%
Cur.Assets 790,007.00
831,758.00
764,358.00
781,307.00
711,655.00
growth rate 5.3% -8.1% 2.2% -8.9%
Total Assets 2,282,572.00
2,303,624.00
2,267,484.00
2,234,113.00
2,266,822.00
growth rate 0.9% -1.6% -1.5% 1.5%
Cash 172,688.00
173,102.00
127,002.00
124,727.00
99,697.00
growth rate 0.2% -26.6% -1.8% -20.1%
Inventory 214,628.00
204,837.00
221,919.00
221,059.00
223,251.00
growth rate -4.6% 8.3% -0.4% 1.0%
Cur.Liabilities 520,723.00
589,949.00
608,410.00
586,423.00
604,075.00
growth rate 13.3% 3.1% -3.6% 3.0%
Liabilities 1,081,221.00
1,102,704.00
1,146,438.00
1,112,800.00
1,155,225.00
growth rate 2.0% 4.0% -2.9% 3.8%
LT Debt 369,091.00
317,937.00
289,854.00
283,462.00
316,730.00
growth rate -13.9% -8.8% -2.2% 11.7%
Equity 916,702.00
916,080.00
851,632.00
888,589.00
880,090.00
growth rate -0.1% -7.0% 4.3% -1.0%
Common Shares 102,046.00
102,046.00
102,046.00
102,046.00
102,046.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 23,210.00
24,397.00
20,614.00
21,471.00
28,762.00
growth rate 5.1% -15.5% 4.2% 34.0%
Cash Dividends 21,552.00
23,706.00
23,706.00
27,660.00
27,660.00
growth rate 10.0% 0.0% 16.7% 0.0%
Cash From OA 65,698.00
59,272.00
-6,953.00
59,488.00
66,451.00
growth rate -9.8% -100.0% 100.0% 11.7%
FCF 42,488.00
34,875.00
-27,567.00
38,017.00
37,689.00
growth rate -17.9% -100.0% 100.0% -0.9%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 502,480.00
509,798.00
434,331.00
495,480.00
508,025.00
growth rate 1.5% -14.8% 14.1% 2.5%
Op.Income 60,045.00
35,771.00
-29,794.00
42,728.00
48,125.00
growth rate -40.4% -100.0% 100.0% 12.6%
IBT 67,096.00
48,194.00
-25,988.00
48,643.00
54,832.00
growth rate -28.2% -100.0% 100.0% 12.7%
Net Income 42,458.00
35,274.00
-40,754.00
33,443.00
33,609.00
growth rate -16.9% -100.0% 100.0% 0.5%
Gross Profit 216,125.00
219,267.00
191,255.00
218,483.00
220,763.00
growth rate 1.5% -12.8% 14.2% 1.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (24.14)

YOY Growth Grade:

F (10.21)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 8.09 8.01
EPS / Growth 2.55

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 39.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 39.6% 39.6% 39.6%
Future PE 0.01 5.40 29.09
Future EPS 71.49 71.49 71.49
Value Price
MOS %
0.18
-99.1%
95.37
367.5%
514.02
2,419.7%
MOS Price 0.09 47.68 257.01
IRT 3.51 3.51 3.51

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.